Article Reuters: Analysis: China’s biotech sector comes of age with big licensing deals, global ambitions

Analysis: China’s biotech sector comes of age with big licensing deals, global ambitions. We’re the living proof of the growing impact of the Chinese life sciences and biotech market!
 
We successfully closed 6 deals between Chinese and European life sciences over the last 12 months. With our boots on the ground in China and Europe, we are actively part of it!
 
Want to learn more about the growing impact of the Chinese life sciences sector? Click here to read the full article.